Feb 9 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 124.11 111.42 165.00
(+11.4 pct) (-7.4 pct) (+6.7 pct)
Operating 15.61 12.39 16.80
(+25.9 pct) (+4.5 pct) (+8.7 pct)
Recurring 15.75 12.97 16.90
(+21.5 pct) (+6.1 pct) (+5.9 pct)
Net 10.10 8.41 10.50
(+20.1 pct) (+7.8 pct) (+4.9 pct)
EPS 88.68 yen 73.93 yen 92.17 yen
EPS Diluted 88.31 yen 73.62 yen
Ann Div 21.00 yen 22.00 yen
-Q2 div 11.00 yen 10.00 yen
-Q4 div 11.00 yen 11.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T
((Tokyo Headline News Desk +813 6441 1812))